Diligence memo · auto-generated · as of July 2, 2026
AI Diagnostics
AI Diagnostics looks fair against its niche peers and is active on financing cadence.
Businessfiled
AI Diagnostics operates in Medical Devices, based in Cape Town, Africa. SA med-tech company AI Diagnostics raises $5.2m to accelerate AI-powered TB screening 0 By Tom Jackson on April 17, 2026 News , Southern Africa South African med-tech company AI Diagnostics has raised ZAR85 million (US$5.2 million) in funding to advance the use of its proprietary hardware and AI software in combatting the tuberculosis (TB) epidemic. Founded in 2020, the Cape Town-based AI Diagnostics develops accessible, early screening tools that empower frontline healthcare workers.
Sub-sector tags: ai/ml, medical-devices.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
AI Diagnostics has raised $5.2M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).
Largest single filing: $5.2M on 2026-04-17.
Most recent recorded round closed around 2026-04-17.
Valuation (modeled)modeled
Provath models AI Diagnostics at approximately $13M (range $6.4M–$18M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 1.23× the median modeled value of Series A Medical Devices companies in 2025–2027 (10 peers) — value vs value, same stage and era. Within the normal band (123% of peer median) for its niche.
Financing rhythm & timingmixed
Last raise 2 mo ago; this sector typically re-raises about every 16 months.
Raising on or ahead of the sector's normal rhythm.
Comparablesmixed
Capital scale ranks ahead of 69% of Medical Devices peers (233 compared).
Modeled value ranks above 54% of those peers.
Closest niche peers: Curadel Surgical Innovations, Inc., Gestalt Diagnostics, LLC, ClearCut Surgical, Inc., Bayou Surgical, Inc., NexEos Diagnostics, Inc..
Risks & flagsmixed
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.